Addresses the inflammatory and vascular drivers of melasma, not just the pigment itself.
Tranexamic acid came to dermatology from haematology, and it treats a part of pigmentation most brightening agents ignore. Melasma involves inflammation and blood-vessel activity underneath the visible patch — which is why it recurs even after the surface lightens. Tranexamic acid interrupts that signalling, and it is one of the few actives with genuine clinical evidence in melasma specifically.
2–5% topically. Effects build over eight to twelve weeks; anyone promising faster is describing a different mechanism, usually a harmful one.
With kojic acid and niacinamide. Especially valuable for hormonal melasma, which resists single-active treatment.
Consult a doctor if you have a history of clotting disorders, even for topical use.
DavaniQ products are cosmetic formulations intended to support skin health and appearance. They are not medicines and are not intended to diagnose, treat or cure any condition. If a concern is persistent, painful or changing, please see a qualified dermatologist.
Rather than guessing from an ingredient list, answer six questions and we'll sequence them for you.
